Health Care & Life Sciences » Pharmaceuticals | Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.28
Market Cap
$403.19 M
Shares Outstanding
102.85 M
Public Float
95.51 M

Profile

Address
355 Alhambra Circle
Coral Gables Florida 33134
United States
Employees -
Website http://www.catalystpharma.com
Updated 07/08/2019
Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on development and commercialization of prescription drugs targeting rare (orphan) neuromuscular and neurological diseases, including Lambert-Eaton Myasthenic Syndrome (LEMS), infantile spasms, and Tourette's disorder. The company was founded by McEnany J.

Financials

View All
Created with Highcharts 5.0.14Catalyst Pharmaceuticals Inc.Net Income. Fiscal year is January-December. All values USD Thousands.12 15412 15415 50915 50920 23320 23318 07218 07218 41218 41234 00334 003201320142015201620172018010k20k30k40k

Patrick J. McEnany
Chairman, President & Chief Executive Officer
David S. Tierney
Independent Director